Mutations Position Table

APOE R176 Mutations


Back to the Top
Mutation Clinical
Phenotype Studied
DNA Change Expected RNA | Protein Consequence Coding/Non-Coding Genomic Region Biological Effect Primary
R176P (R158P)
(Osaka/Kurashiki, ApoE Osaka/Kurashiki, ApoE2 Kurashiki, ApoE Osaka)
Blood Lipids/Lipoproteins, Cardiovascular Disease, Kidney Disorder: Lipoprotein Glomerulopathy Substitution Substitution | Missense Coding Exon 4

Unknown, but structural analyses predicted changes affecting lipid and receptor binding.

Tokura et al., 2011;
Mitani et al., 2011
[C130R;R176C] ([C112R;R158C])
(ApoE3r, ApoE1y)
Blood Lipids/Lipoproteins, Motor Neuron Disease Coding Exon 4


Persico et al., 2004
[R176C];[C130R] ([R158C;C112R])
(ApoE2/4, ApoE4/2)
Alzheimer's Disease, Multiple Conditions Coding Exon 4

When present in the same host, APOE2 appears to partially mitigate APOE4's harmful effects.

Farrer et al., 1997
R176C (R158C)
Alzheimer's Disease, Multiple Conditions Allele Allele | Allele Coding Exon 4

Protective against AD risk. Effects on both Aβ (direct) and tau (possibly indirect) pathologies. Also implicated in multiple neuronal and non-neuronal functions.

Weisgraber et al., 1981;
Zannis and Breslow, 1981

Disclaimer: Alzforum does not provide medical advice. The Content is for informational, educational, research and reference purposes only and is not intended to substitute for professional medical advice, diagnosis or treatment. Always seek advice from a qualified physician or health care professional about any medical concern, and do not disregard professional medical advice because of anything you may read on Alzforum.